Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context

被引:52
作者
De Angelis, F. [1 ,2 ]
Pujia, A. [1 ]
Falcone, C. [3 ]
Iaccino, E. [3 ]
Palmieri, C. [3 ]
Liberale, C. [1 ,2 ]
Mecarini, F. [1 ]
Candeloro, P. [2 ]
Luberto, L. [3 ]
de Laurentiis, A. [3 ]
Das, G. [1 ]
Scala, G. [3 ]
Di Fabrizio, E. [1 ,2 ]
机构
[1] Fdn Ist Italiano Tecnol, I-16163 Genoa, Italy
[2] Magna Graecia Univ Catanzaro, BIONEM Lab, I-88100 Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy
关键词
MESOPOROUS SILICON MICROPARTICLES; ANTIGEN-BINDING RECEPTOR; POROUS SILICON; PEPTIDE LIGANDS; SURFACE-CHEMISTRY; PORE-SIZE; CANCER; LYMPHOMA; EPITOPE; PHAGE;
D O I
10.1039/c0nr00161a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Multitasking nanoparticles are gaining great attention for smart drug delivery systems. The exploration of the nano-scale opens new concrete opportunities for revealing new properties and undiscovered cell-particle interactions. Here we present a biodegradable nanoporous silicon nanoparticle that can be successfully employed for in vivo targeted drug delivery and sustained release. The bare nanoporous nanocarriers can be accurately designed and fabricated with an effective control of porosity, surface chemistry and particle size, up to a few nm. The proposed nanoparticles exhibit several remarkable features including high payload, biodegradability, no toxicity, and multiple loading in water without the need of additional chemical reagents at room temperature. The targeting strategy is based on phage display technology that was successfully used to discover cell surface binding peptide for murine B lymphoma A20 cell line. The peptide used in combination with the nanoporous nanoparticles allows an efficient in vivo targeting, a sustained release and a sensible therapeutic effect.
引用
收藏
页码:2230 / 2236
页数:7
相关论文
共 31 条
[1]   Therapeutic cancer targeting peptides [J].
Aina, OH ;
Sroka, TC ;
Chen, ML ;
Lam, KS .
BIOPOLYMERS, 2002, 66 (03) :184-199
[2]   From combinatorial chemistry to cancer-targeting peptides [J].
Aina, Olulanu H. ;
Liu, Ruiwu ;
Sutcliffe, Julie L. ;
Marik, Jan ;
Pan, Chong-Xian ;
Lam, Kit S. .
MOLECULAR PHARMACEUTICS, 2007, 4 (05) :631-651
[3]   Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions [J].
Anderson, SHC ;
Elliott, H ;
Wallis, DJ ;
Canham, LT ;
Powell, JJ .
PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE, 2003, 197 (02) :331-335
[4]   Porous silicon in drug delivery devices and materials [J].
Anglin, Emily J. ;
Cheng, Lingyun ;
Freeman, William R. ;
Sailor, Michael J. .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (11) :1266-1277
[5]   Active targeting schemes for nanoparticle systems in cancer therapeutics [J].
Byrne, James D. ;
Betancourt, Tania ;
Brannon-Peppas, Lisa .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) :1615-1626
[6]   EPITOPE DISCOVERY USING PEPTIDE LIBRARIES DISPLAYED ON PHAGE [J].
CORTESE, R ;
FELICI, F ;
GALFRE, G ;
LUZZAGO, A ;
MONACI, P ;
NICOSIA, A .
TRENDS IN BIOTECHNOLOGY, 1994, 12 (07) :262-267
[7]  
Cortese Riccardo, 1995, Current Opinion in Biotechnology, V6, P73, DOI 10.1016/0958-1669(95)80012-3
[8]   Anti-idiotype antibodies in cancer treatment [J].
de Cerio, A. Lopez-Diaz ;
Zabalegui, N. ;
Rodriguez-Calvillo, M. ;
Inoges, S. ;
Bendandi, M. .
ONCOGENE, 2007, 26 (25) :3594-3602
[9]   The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis [J].
Emerich, Dwaine F. ;
Thanos, Christopher G. .
BIOMOLECULAR ENGINEERING, 2006, 23 (04) :171-184
[10]   Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines [J].
Graner, M ;
Raymond, A ;
Akporiaye, E ;
Katsanis, E .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (09) :476-484